Mouse anti- Human Retinol-binding protein 4 monoclonal antibody

Product Type: Monoclonal antibodies
Product Name: Mouse anti- Human Retinol-binding protein 4 monoclonal antibody
Size: 100ug
Code: CSB-MA074271A0m
Immunogen: Recombinant Human Retinol-binding protein 4 protein
Raised in: mouse
Species Reactivity: Human
Spectificity: specific for native and denatured forms
Tested Applications: ELISA, WB, and other possible application
Relevance: Retinol (Vitamin A) is transported in the blood bound to its carrier protein, retinol-binding protein (RBP), also designated plasma retinol-binding protein (PRBP) or RBP4. A member of the lipocalin family, RBP conveys retinol from stores in the liver to p
Clonality: monoclonal
Isotype: IgG1
Purity: >95% by Caprylic Acid Ammonium Sulfate Precipitation purified
Conjugate: Non-conjugated
Storage Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Form: liquid
Storage: Store at +4C short term (1-2 weeks). Aliquot and store at -20C or -80C. Avoid repeated freeze / thaw cycles
References: [1] Zhou F, Huang Q, Dai X, Yin J, Wu J, Zhou H, Gong Z, Liu Z. Impact of retinol binding protein 4 polymorphism on rosiglitazone response in Chinese Type 2 diabetic patients. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Oct;36(10):949-57. [2] Mellati AA, Sharifi F, Sajadinejad M, Sohrabi D, Mazloomzadeh S. The relationship between retinol-binding protein 4 levels, insulin resistance, androgen hormones and polycystic ovary syndrome. Scand J Clin Lab Invest. 2011 Oct 24. [3] Lorkova L, Pospisilova J, Lacheta J, Leahomschi S, Zivny J, Cibula D, Zivny J, Petrak J. Decreased concentrations of retinol-binding protein 4 in sera of epithelial ovarian cancer patients: A potential biomarker identified by proteomics. Oncol Rep. 2011 Oct 21. doi: 10.3892/or.2011.1513. [4] Shaker O, El-Shehaby A, Zakaria A, Mostafa N, Talaat S, Katsiki N, Mikhailidis DP. Plasma visfatin and retinol binding protein-4 levels in patients with type 2 diabetes mellitus and their relationship to adiposity and fatty liver. Clin Biochem. 2011 Dec;44(17-18):1457-63. Epub 2011 Sep 12. [5] Chen PY, Huang MC, Chiu CC, Liu HC, Lu ML, Chen CH. Association of plasma retinol-binding protein-4, adiponectin, and high molecular weight adiponectin with metabolic adversities in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 1;35(8):1927-32. Epub 2011 Aug 5. [6] Chu CH, Lam HC, Lee JK, Lu CC, Sun CC, Cheng HJ, Wang MC, Chuang MJ. Elevated serum retinol-binding protein 4 concentrations are associated with chronic kidney disease but not with the higher carotid intima-media thickness in type 2 diabetic subjects. Endocr J. 2011 Oct 29;58(10):841-7. Epub 2011 Aug 4. [7] Ahn KJ, Choi EA, Kim J, Lee JH, Lee KH, Bang D, Cho SB. Increased retinol-binding protein (RBP) 4 and anti-RBP4 antibody in alopecia areata. Br J Dermatol. 2011 Oct;165(4):837-44. doi: 10.1111/j.1365-2133.2011.10482.x. [8] Chan TF, Tsai YC, Wu CH, Lee CH, Wang SH, Su JH. The positive correlation between cord serum retinol-binding protein 4 concentrations and fetal growth. Gynecol Obstet Invest. 2011;72(2):98-102. Epub 2011 Jun 16. [9] Rhie YJ, Choi BM, Eun SH, Son CS, Park SH, Lee KH. Association of serum retinol binding protein 4 with adiposity and pubertal development in Korean children and adolescents. J Korean Med Sci. 2011 Jun;26(6):797-802. Epub 2011 May 18. [10] Park CS, Ihm SH, Park HJ, Shin WS, Kim PJ, Chang K, Kim HY, Youn HJ, Chung WS, Seung KB, Kim JH. Relationship between plasma adiponectin, retinol-binding protein 4 and uric Acid in hypertensive patients with metabolic syndrome. Korean Circ J. 2011 Apr;41(4):198-202. [11] Christou GA, Tellis CC, Elisaf MS, Tselepis AD, Kiortsis DN. The Changes in Plasma Retinol-Binding Protein 4 Levels are Associated With Those of the Apolipoprotein B-Containing Lipoproteins During Dietary and Drug Treatment. Angiology. 2011 May 20.
Intended use: